[go: up one dir, main page]

NO943288L - Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease - Google Patents

Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease

Info

Publication number
NO943288L
NO943288L NO943288A NO943288A NO943288L NO 943288 L NO943288 L NO 943288L NO 943288 A NO943288 A NO 943288A NO 943288 A NO943288 A NO 943288A NO 943288 L NO943288 L NO 943288L
Authority
NO
Norway
Prior art keywords
pentoxyphylline
granulomatosis
treatment
lung disease
preparation
Prior art date
Application number
NO943288A
Other languages
Norwegian (no)
Other versions
NO943288D0 (en
Inventor
Peter Zabel
Ulrich Schade
Original Assignee
Rentschler Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rentschler Arzneimittel filed Critical Rentschler Arzneimittel
Publication of NO943288D0 publication Critical patent/NO943288D0/en
Publication of NO943288L publication Critical patent/NO943288L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet anvendelsen av pentoksyfyllin, eventuelt i kombinasjon med ytterligere terapeu- tiske virkestoffer ved fremstilling av farmasøytis- ke preparater til behandling av granulomatese og fibroserende lungesykdommer.The use of pentoxyphylline has been described, optionally in combination with additional therapeutic agents in the manufacture of pharmaceutical compositions for the treatment of granulomatosis and fibrosis lung disease.

NO943288A 1993-09-21 1994-09-06 Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease NO943288L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4332041A DE4332041C2 (en) 1993-09-21 1993-09-21 Use of pentoxifylline in certain lung diseases

Publications (2)

Publication Number Publication Date
NO943288D0 NO943288D0 (en) 1994-09-06
NO943288L true NO943288L (en) 1995-03-22

Family

ID=6498198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943288A NO943288L (en) 1993-09-21 1994-09-06 Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease

Country Status (7)

Country Link
EP (1) EP0670163A1 (en)
JP (1) JPH07247215A (en)
CZ (1) CZ230094A3 (en)
DE (1) DE4332041C2 (en)
HU (1) HUT70054A (en)
NO (1) NO943288L (en)
SK (1) SK111894A3 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
FR2779063A1 (en) * 1998-05-29 1999-12-03 Assist Publ Hopitaux De Paris PENTOXIFYLLIN COMPOSITIONS AND THEIR THERAPEUTIC USE
ECSP003747A (en) * 1999-11-02 2002-05-23 Smithkline Beecham Corp METHOD AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
AU2001264286A1 (en) * 2000-06-16 2001-12-24 Chugai Seiyaku Kabushiki Kaisha Preventives/remedies for granuloma
US20060083714A1 (en) * 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
EP2156826A1 (en) * 2004-09-27 2010-02-24 Sigmoid Pharma Limited Microcapsule formulations comprising two pharmaceutically active ingredients
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
JP5640079B2 (en) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ Oil droplet-containing composition
BR112012002963A2 (en) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
KR101512223B1 (en) * 2013-02-22 2015-04-24 가톨릭대학교 산학협력단 anti-cancer adjuvant comprising pentoxifylline
EA036036B1 (en) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Compositions comprising cyclosporin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method

Also Published As

Publication number Publication date
DE4332041A1 (en) 1995-03-23
HUT70054A (en) 1995-09-28
HU9402709D0 (en) 1995-02-28
JPH07247215A (en) 1995-09-26
CZ230094A3 (en) 1995-04-12
EP0670163A1 (en) 1995-09-06
NO943288D0 (en) 1994-09-06
SK111894A3 (en) 1995-05-10
DE4332041C2 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
BG101118A (en) Therapeutical compounds
TR199801180T2 (en) New compounds with analgesic effect.
NO985464L (en) Concentrated antibody preparation
GEP20063799B (en) Tropane derivatives useful in therapy
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
IS1907B (en) Use of the chelating agent clioquinol in the preparation of a pharmaceutical composition for the treatment of Alzheimer's disease
MY119403A (en) Novel compounds with analgesic effect.
NO954878L (en) pyrrole
NO954996D0 (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
NO952309D0 (en) Use of riluzole in the treatment of Parkinson's disease and Parkinson's syndromes
GB9806632D0 (en) Peptide factor
NO943288L (en) Use of pentoxyphylline in the preparation of pharmaceutical preparations for the treatment of granulomatosis and fibrosis lung disease
DE69434121D1 (en) PHARMACEUTICAL COMPOSITION FOR IMMUNITIMULATING THERAPY
PL329802A1 (en) Derivatives of androstene
NO972391D0 (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and their preparations and methods
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
WO1998009599A3 (en) The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
DE69200711D1 (en) Pharmaceutical compositions containing fluticasone propionate and oxikonazole or its salt for topical use.
ATE139226T1 (en) AMINOSULFONYL UREA ACAT INHIBITORS
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
ATE271852T1 (en) IMPROVED INHALATION PREPARATIONS
PL368686A1 (en) Novel aminobenzoephenones
EP0795332A3 (en) Medical use of gamma-interferon in interstitial lung diseases
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.